1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLCnon-small cell lung carcinomaActive, not recruitingPhase 22026-10-01NCT05798663